Rapid Micro Biosystems, Inc.
RPID · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $28,051 | $22,519 | $17,133 | $23,232 |
| % Growth | 24.6% | 31.4% | -26.3% | – |
| Cost of Goods Sold | $28,160 | $28,004 | $25,673 | $30,973 |
| Gross Profit | -$109 | -$5,485 | -$8,540 | -$7,741 |
| % Margin | -0.4% | -24.4% | -49.8% | -33.3% |
| R&D Expenses | $14,597 | $12,820 | $12,866 | $9,781 |
| G&A Expenses | $21,947 | $24,936 | $26,819 | $17,895 |
| SG&A Expenses | $35,213 | $38,258 | $41,813 | $29,710 |
| Sales & Mktg Exp. | $13,266 | $13,322 | $14,994 | $11,815 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $49,810 | $51,078 | $54,679 | $39,491 |
| Operating Income | -$49,919 | -$56,563 | -$63,219 | -$47,232 |
| % Margin | -178% | -251.2% | -369% | -203.3% |
| Other Income/Exp. Net | $3,052 | $4,127 | $1,837 | -$26,201 |
| Pre-Tax Income | -$46,867 | -$52,436 | -$61,382 | -$73,433 |
| Tax Expense | $22 | $31 | -$576 | $91 |
| Net Income | -$46,889 | -$52,467 | -$60,806 | -$73,524 |
| % Margin | -167.2% | -233% | -354.9% | -316.5% |
| EPS | -1.08 | -1.22 | -1.43 | -1.88 |
| % Growth | 11.5% | 14.7% | 23.9% | – |
| EPS Diluted | -1.08 | -1.22 | -1.43 | -1.88 |
| Weighted Avg Shares Out | 43,576 | 43,024 | 42,454 | 41,467 |
| Weighted Avg Shares Out Dil | 43,576 | 43,024 | 42,454 | 41,467 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,164 | $4,210 | $1,778 | $0 |
| Interest Expense | $0 | $0 | $0 | $2,650 |
| Depreciation & Amortization | $3,362 | $3,105 | $2,837 | $1,529 |
| EBITDA | -$46,557 | -$53,458 | -$60,382 | -$45,703 |
| % Margin | -166% | -237.4% | -352.4% | -196.7% |